Herceptin ( Trastuzumab)

Herceptin

Herceptin (trastuzumab) Wholesaler

Herceptin (trastuzumab)  , wholesaler

HERCEPTIN (TRASTUZUMAB) DESCRIPTION:

Trastuzumab is a humanized IgG1 kappa monoclonal antibody that selectively binds with high affinity to the extracellular domain of the human epidermal growth factor receptor 2 protein, HER2. Trastuzumab is produced by recombinant DNA technology in a mammalian cell (Chinese Hamster Ovary) culture which may contain the antibiotic gentamicin. Gentamicin is not detectable in the final product.

HERCEPTIN (TRASTUZUMAB) INDICATIONS:

Adjuvant Breast Cancer

Herceptin is indicated for adjuvant treatment of HER2 overexpressing node positive or node negative (ER/PR negative or with one high risk feature [see Clinical Studiesbreast cancer

Metastatic Breast Cancer

  • In combination with paclitaxel for first-line treatment of HER2-overexpressing metastatic breast cancer
  • As a single agent for treatment of HER2-overexpressing breast cancer in patients who have received one or more chemotherapy regimens for metastatic disease.

Metastatic Gastric Cancer

Herceptin is indicated, in combination with cisplatin and capecitabine or 5-fluorouracil, for the treatment of patients with HER2-overexpressing metastatic gastric or gastroesophageal junction adenocarcinoma who have not received prior treatment for metastatic disease.

DOSAGE FORM & STRENGTH:

  • Herceptin 150mg  distributor, supplier, wholesaler
  • Herceptin 420mg wholesaler

Rasso Swiss Pharma is a Herceptin (Trastuzumab) wholesaler distributor, supplier. 

<< Back to products